share_log

ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate

Benzinga ·  Aug 7 16:26

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 44.83 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $7.858 million which beat the analyst consensus estimate of $7.330 million by 7.21 percent. This is a 32.07 percent increase over sales of $5.950 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment